Minoryx Therapeutics
Clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€93—139m (Dealroom.co estimates May 2022.)
Company register number B65648156
Mataró Catalonia (HQ)
Authorizing premium user...